A Day Up For Cyclacel Pharmaceuticals, Inc.
Tue, Dec 22, 2020 at 05:30 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) soared at $6.4, representing a gain of 49.5%. The stock appeared on our News Catalysts scanner on Tue 22 Dec 20 at 11:08 AM in the 'INVESTOR UPDATE' category. From Mon 07 Dec 20, the stock recorded 50.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Ocugen, Inc. (OCGN:NASDAQ), 173.88%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 83.52%
- MicroVision, Inc. (MVIS:NASDAQ), 60.66%
- Big Rock Partners Acquisition Corp. (BRPA:NASDAQ), 55.94%
- Aurora Mobile Limited (JG:NASDAQ), 50.16%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 49.53%
- Aqua Metals, Inc. (AQMS:NASDAQ), 47.93%
- LightPath Technologies, Inc. (LPTH:NASDAQ), 39.94%
- Sportsman's Warehouse Holdings, Inc. (SPWH:NASDAQ), 39.6%
- QS (QS:NYSE), 38.75%